China Cord Blood Corporation Announces Participation in the 31st Annual J.P. Morgan Healthcare Conference

HONG KONG, Dec. 27, 2012 /PRNewswire-FirstCall/ -- China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"), the first and largest cord blood banking operator in China, today announced that the Company will participate in the 31^st Annual J.P. Morgan Healthcare Conference to be held January 7-10, 2013 at the Westin St. Francis Hotel in San Francisco. Management is scheduled to present on Wednesday, January 9, 2013 and to meet with institutional investors throughout the day.

For further details, please contact your J.P. Morgan institutional sales representatives.

About China Cord Blood Corporation

China Cord Blood Corporation is the first and largest umbilical cord blood banking operator in China in terms of geographical coverage and is the only cord blood banking operator with multiple licenses.  Under current PRC government regulations, only one licensed cord blood banking operator is permitted to operate in each licensed region and only seven licenses have been authorized as of today. China Cord Blood Corporation provides cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services.  For more information, please visit the Company's website at http://www.chinacordbloodcorp.com.    

For more information, please contact:
China Cord Blood Corporation
Investor Relations Department
Tel: (+852) 3605-8180
Email: ir@chinacordbloodcorp.com  

ICR, Inc.
Mr. Rob Koepp
Tel: (+86) 10-6583-7516 or (646) 405-5185
Email: robert.koepp@icrinc.com

 

SOURCE China Cord Blood Corporation

RELATED LINKS
http://www.chinacordbloodcorp.com